Monopar Therapeutics (MNPR) PT Raised to $128 at Barclays
Tweet
Share
E-mailGet Alerts MNPR Hot Sheet
Price: $85.24 -4.05%
Rating Summary:
14 Buy, 2 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
14 Buy, 2 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
Barclays analyst Etzer Darout raised the price target on Monopar Therapeutics (NASDAQ: MNPR) to $128.00 (from $125.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
- Akamai Technologies (AKAM) PT Raised to $149 at TD Cowen
- Nutex Health (NUTX) PT Raised to $306 at Freedom Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
